MedTrace Logo

Scalp Nerve Block and Opioid Consumption in Brain Surgery

NCT02057367 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-07-27

No results posted yet for this study

Summary

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

Conditions

  • Brain Tumour

Interventions

DRUG

Scalp block with 0.5% plain Marcaine

Anterior scalp block will be done by using 0.5% plain Marcaine 20 ml.

DRUG

Scalp block with 0.9% normal saline

Anterior scalp block will be done by using 0.9% normal saline 20 ml.

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Pathomporn Pin-on, M.D. · Chiang Mai University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-02-29
Completion
2016-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057367 on ClinicalTrials.gov